PFM Health Sciences: Holdings Comparison Q3 2022 vs. Q4 2022

In the world of finance, keeping track of the holdings of a hedge fund or investment firm is crucial. These holdings provide an insight into the firm's overall strategy and can predict its future success. One way to do this is through the 13F filings, which disclose the firm's holdings of publicly traded securities. In this blog post, we will explore the changes in holdings of PFM Health Sciences LP through the comparison of the Q3 2022 and Q4 2022 13F filings.

The PFM Health Sciences LP fund holds shares in several pharmaceutical and healthcare companies, including Horizon Therapeutics Pub L, Cytokinetics Inc, and Eli Lilly & Co. Let's look at several of the fund's notable position changes.

Horizon Therapeutics Pub L

During Q3 2022 and Q4 2022, PFM Health Sciences LP held 1,091,840 shares and maintained that position through both quarters. However, the value of the shares held increased by 83.9%, from $67,574,000 to $124,251,000, respectively.

Cytokinetics Inc

The PFM Health Sciences LP fund reduced its position in Cytokinetics Inc by 7.9%, holding 2,465,016 shares in Q3 2022, but only 2,399,545 in Q4 2022.

Eli Lilly & Co

The fund also increased its position in Eli Lilly & Co, holding 298,643 shares in both Q3 2022 and Q4 2022. However, the value of the shares held increased by 13.1%, from $96,566,000 to $109,255,000, respectively.

Merck & Co Inc

Merck & Co has two positions in PFM Health Sciences LP's portfolio, one being a call option and the other being a standard position. Notably, the fund acquired 871,500 shares of Merck & Co call option, which was absent in Q3 2022. The fund's other position of Merck & Co increased in shares from 360,520 to 367,634. The value of the standard position increased by 31.4%, from $31,048,000 to $40,788,000.

Centene Corp Del

The PFM Health Science LP fund increased its position in Centene Corp Del by 5.4%, holding 1,112,480 shares in both Q3 2022 and Q4 2022. However, the value of the shares held increased by only 5.4%, from $86,562,000 to $91,234,000, respectively.

UnitedHealth Group Inc

The PFM Health Science LP fund increased its position in UnitedHealth Group Inc by 9.2%, holding 111,554 shares in Q3 2022 and 116,067 shares in Q4 2022. However, the value of the shares held increased by only 9.2%, from $56,339,000 to $61,536,000, respectively.

In conclusion, PFM Health Sciences LP made several notable changes to their portfolio holdings in the pharmaceutical and healthcare sectors. While some positions decreased, others increased, and the fund acquired new positions. Despite the changes, the overall value of the fund's holdings increased from Q3 2022 to Q4 2022.